Pcn301 - Health Technology Assessment for Chimeric Antigen Receptor (Car) T-Cell Therapies for Cancer
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.383
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV